ChemoMetec ASFRA:CHY -0.49%99 Dividend Yield % is 1.92% as of Jun. 26, 2026, which is 79% above its 10-year median of 1.07. GuruFocus rates FRA:CHY with a GF Score™ of 99/100 and a GF Value™ of €69.05 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 328 Medical Devices & Instruments companies, ChemoMetec AS ranks worse than 51.83% on this metric.
As of today (2026-06-26), the Trailing Annual Dividend Yield of ChemoMetec AS is 1.92%.
Good Sign:
ChemoMetec AS stock Dividend Yield % is close to 5-year high.
The historical rank and industry rank for ChemoMetec AS's Dividend Yield % or its related term are showing as below:
FRA:CHY'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.14 Med: 1.07 Max: 2.22
Current: 1.92
During the past 13 years, the highest Dividend Yield of ChemoMetec AS was 2.22%. The lowest was 0.14%. And the median was 1.07%.
FRA:CHY's Dividend Yield % is ranked worse than 51.83% of 328
companies
in the Medical Devices & Instruments industry
Industry Median: 2
vs FRA:CHY: 1.92
During the past 12 months, ChemoMetec AS's average Dividends Per Share Growth Rate was 75.00% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of ChemoMetec AS was 58.70% per year. The lowest was 58.70% per year. And the median was 58.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
ChemoMetec AS (FRA:CHY) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for ChemoMetec AS's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:CHY vs ABT, SYK, MDT: Dividend Yield % Comparison
For the Medical Devices subindustry, ChemoMetec AS's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
ChemoMetec AS Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
DKK 7.000000
2025-10-10
2025-10-13
2025-10-14
Cash Dividend
annually
DKK:EUR 0.133943
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
ChemoMetec AS's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.937601
/
48.74
=
1.92 %
Current Share Price is €48.74. ChemoMetec AS's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.937601.
ChemoMetec AS's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.937601
/
48.74
=
1.92 %
Current Share Price is €48.74. ChemoMetec AS's Dividends per Share for the forward twelve months is calculated as €0.937601 * 1 = €0.937601.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS (FRA:CHY) has a Dividend Yield % of 1.92% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on ChemoMetec AS and its competitors. This is 79% above median its historical median of 1.07. Over the past decade, ChemoMetec AS's Dividend Yield % has ranged from 0.14 to 2.22. According to the industry distribution chart, ChemoMetec AS ranks #170 out of 328 companies in the Medical Devices & Instruments industry, placing it in the top 51.8%.
Is ChemoMetec AS's Dividend Yield % too high?
ChemoMetec AS's current Dividend Yield % of 1.92% is 79% above median its 10-year median of 1.07. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 2.22. The Medical Devices & Instruments industry median Dividend Yield % is 2.00. ChemoMetec AS's value of 1.92% is 4% below this industry median. Based on the distribution chart, ChemoMetec AS ranks #170 out of 328 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ChemoMetec AS ranks #170 out of 328 companies for Dividend Yield %. This places ChemoMetec AS in the lower half of its industry. The industry median Dividend Yield % is 2.00. ChemoMetec AS's value of 1.92% is 4% below this benchmark. Historically, ChemoMetec AS's own Dividend Yield % has ranged from 0.14 to 2.22 over the past decade. While the company's 10-year median is 1.07 vs. the industry median of 2.00, ChemoMetec AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 2.00, based on 328 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ChemoMetec AS's current Dividend Yield % of 1.92% is 4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on ChemoMetec AS and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ChemoMetec AS's current Dividend Yield % is 1.92%, which is 79% above median its own 10-year median of 1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (FRA:CHY) is currently considered Modestly Undervalued. The stock's GF Value™ is €69.05, compared to a current price of €48.74 — trading 29.4% below its estimated fair value. The current Dividend Yield % is 1.92%, which is 79% above median its 10-year median of 1.07 and 4% below the Medical Devices & Instruments industry median of 2.00. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For ChemoMetec AS (FRA:CHY), the current Dividend Yield % is 1.92% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ChemoMetec AS (FRA:CHY) Overvalued in 2026?
Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued.
The current stock price of €48.74 is trading 29.4% below its estimated GF Value™ of €69.05.
GuruFocus considers ChemoMetec AS to be Modestly Undervalued.
Key valuation signals for FRA:CHY:
Dividend Yield %: 1.92% (79% above median its 10-year median of 1.07)
GF Value™: €69.05 vs. price of €48.74 (29.4% below fair value)
Industry Position: 4% below the Medical Devices & Instruments median (#170 of 328)
No single metric tells the full story. See the FRA:CHY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score
Get the complete analysis for FRA:CHY
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:CHY has been successfully added to your 
